Clinical Trial Update: Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the combination of lapatinib and temozolomide for progressive brain metastases in HER2-positive metastatic breast cancer and has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Temodar (Temozolomide)
• Tykerb (lapatinib)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Metastatic Breast Cancer, Brain Metastases | Phase 1 | Status: COMPLETED